web site hit counter Biotechnology Valuation: An Introductory Guide - Ebooks PDF Online
Hot Best Seller

Biotechnology Valuation: An Introductory Guide

Availability: Ready to download

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start. --Chris Blackwell, Chief Executive, Vectura Group plc A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians. --Steve Winokur, Managing Director, CanaccordAdams A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value. --Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge A fabulous approach to a difficult topic. --Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company


Compare

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start. --Chris Blackwell, Chief Executive, Vectura Group plc A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians. --Steve Winokur, Managing Director, CanaccordAdams A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value. --Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge A fabulous approach to a difficult topic. --Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company

22 review for Biotechnology Valuation: An Introductory Guide

  1. 4 out of 5

    Jose Parra

    This review has been hidden because it contains spoilers. To view it, click here. Interesting project valuation example in page 122 using backward dinĂ¡mica programming

  2. 5 out of 5

    Stephen Peterson

  3. 5 out of 5

    Kai Wong

  4. 4 out of 5

    Apurva Deshpande

  5. 5 out of 5

    Ah

  6. 4 out of 5

    Eric Vieira

  7. 5 out of 5

    Romina Hidalgo

  8. 5 out of 5

    Alexix tewodros

  9. 5 out of 5

    Daniel Janse

  10. 4 out of 5

    Fundamentals of Bioscience Industry Program

  11. 5 out of 5

    Martin

  12. 4 out of 5

    Arian A

  13. 4 out of 5

    Mark

  14. 4 out of 5

    Reader

  15. 4 out of 5

    psnlee

  16. 5 out of 5

    Ipshita

  17. 5 out of 5

    Elly Setiawaty

  18. 5 out of 5

    Nicholas Lawson

  19. 5 out of 5

    Thomas Harris

  20. 5 out of 5

    Sapphire Ng

  21. 4 out of 5

    Jaak

  22. 5 out of 5

    Matthew Coleman

Add a review

Your email address will not be published. Required fields are marked *

Loading...
We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.